Variant report
Variant | esv3352457 |
---|---|
Chromosome Location | chr7:17100234-17100742 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:17100496..17103422-chr7:17133231..17136201,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139107169 | chr7:17100234-17100235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs180711056 | chr7:17100251-17100252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561236052 | chr7:17100268-17100269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75195447 | chr7:17100269-17100270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1030510 | chr7:17100273-17100274 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs78224952 | chr7:17100275-17100276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532433359 | chr7:17100310-17100311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184003226 | chr7:17100326-17100327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566611720 | chr7:17100333-17100334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533852219 | chr7:17100337-17100338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549308975 | chr7:17100371-17100372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567547856 | chr7:17100391-17100392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537876131 | chr7:17100411-17100412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556163598 | chr7:17100412-17100413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs62444471 | chr7:17100425-17100426 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs538681900 | chr7:17100426-17100427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554081422 | chr7:17100551-17100552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572640010 | chr7:17100598-17100599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188444515 | chr7:17100604-17100605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376665833 | chr7:17100623-17100624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143979454 | chr7:17100646-17100647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562474164 | chr7:17100691-17100692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146462526 | chr7:17100701-17100702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs6942599 | chr7:17100702-17100703 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs564906671 | chr7:17100725-17100726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143152477 | chr7:17100739-17100740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373398660 | chr7:17100742-17100743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 21183584 | CNVD |
Autism | 20808228 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Autism | 22495309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:17095600-17108800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr7:17096800-17100400 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr7:17098800-17101600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr7:17098800-17102400 | Weak transcription | Osteobl | bone |
5 | chr7:17098800-17107800 | Weak transcription | HMEC | breast |
6 | chr7:17099000-17101200 | Weak transcription | NHDF-Ad | bronchial |
7 | chr7:17099000-17102400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr7:17099000-17102400 | Weak transcription | HUVEC | blood vessel |
9 | chr7:17099200-17100400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr7:17099400-17102400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr7:17100000-17102200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
12 | chr7:17100000-17102400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr7:17100200-17100400 | Enhancers | Dnd41 | blood |
14 | chr7:17100400-17102200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
15 | chr7:17100400-17104600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |